News

Ulcerated Melanomas May Respond to Interferon

Publish date: August 1, 2009
PDF Download

 

Dr. Eggermont had no conflict of interest disclosures. Dr. Gajewski disclosed receiving honoraria and/or research funding from Bristol-Myers Squibb Co., Genentech Inc., GlaxoSmithKline, and Pfizer Inc.

Ulcerated melanoma is a distinct biological entity with much worse prognosis.

Source DR. EGGERMONT

Pages

Recommended Reading

Leukemia Mortality Linked to Prior Skin Cancer
MDedge Dermatology
Skin Regimen Prevents Cancer Tx-Related Rashes
MDedge Dermatology
Sebaceous Cell Carcinoma Responds Well to Mohs
MDedge Dermatology
BCC Is Most Common Form Of Periocular Skin Cancer
MDedge Dermatology
Two UVA Sunscreen Filters Are Better Than One
MDedge Dermatology
Saffron
MDedge Dermatology
Celecoxib May Prevent Skin Cancer, Study Finds
MDedge Dermatology
Malanoma Arising in African-, Asian-, Latino- and Native-American Populations
MDedge Dermatology
Nonmelanoma Skin Cancer in Persons of Color
MDedge Dermatology
Giant Intradiploic Epidermoid Cyst of the Skull: A Case Report and Management of Large Cystic Scalp Masses
MDedge Dermatology